Fri Sep 20 08:14:49 UTC 2024: ## American Healthcare REIT (AHR) Receives “Moderate Buy” Rating from Analysts

**New York, NY – September 20, 2024** – American Healthcare REIT, Inc. (NYSE: AHR) has received an average recommendation of “Moderate Buy” from eight brokerage firms covering the stock, according to Marketbeat Ratings. This rating is based on one “Hold” recommendation and seven “Buy” recommendations. The average twelve-month price target among analysts is $20.38.

Several brokerages have recently issued positive reports on AHR. Bank of America upgraded its price objective to $27.00 from $19.00, maintaining a “Buy” rating. Similarly, Truist Financial and Morgan Stanley both raised their price targets to $22.00, while JMP Securities increased their target to $18.00. KeyCorp also upgraded AHR, raising its target price to $27.00.

Despite missing analysts’ EPS estimates for the quarter ending August 5th, AHR reported a 7.9% increase in revenue year-over-year, reaching $504.60 million. Analysts anticipate a 1.28 EPS for the current year. The company also declared a quarterly dividend of $0.25 per share, representing a $1.00 annualized dividend and a yield of 3.94%.

Institutional investor interest in AHR remains strong, with several firms adding to their positions in the first quarter, including Peak Financial Advisors LLC, Sumitomo Mitsui Trust Holdings Inc., Peregrine Capital Management LLC, Principal Financial Group Inc., and Capstone Investment Advisors LLC. Institutional investors currently own 16.68% of the company’s stock.

American Healthcare REIT, formed through a merger and acquisition, is one of the largest healthcare-focused REITs globally, with assets totaling approximately $4.2 billion in gross investment value.

**Disclaimer:** This news article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with a qualified financial professional before making any investment decisions.

Read More